Dec 12, 2014, 00:00 by Michael Croft

Inc.com | Many have tried to start a 'LinkedIn for doctors,' but Doximity has signed up 400,000 doctors by allowing them to exchange valuable medical information.

Dec 11, 2014, 11:00 by Michael Croft

Clinical Informatics News | In late October, Medidata acquired Patient Profiles, an early-stage software company focused on improving clinical trial data quality. Yesterday, the company has announced an enriched solution for risk-based monitoring (RBM) of clinical trials using the Patient Profiles technology. It's a perfect "small bite" entry to RBM, the company says.

Dec 10, 2014, 16:15 by Michael Croft

Aeon | As American medicine spends more and more effort controlling biomarkers like cholesterol and prostate-specific antigens to make incremental gains against disease risk, it may be time to consider how much risk is acceptable, and how much intervention is too much.

Dec 10, 2014, 14:00 by Michael Croft

Clinical Informatics News | In February, Clinical Informatics News will be attending the 2015 Summit for Clinical Ops Executives—SCOPE—in Orlando, Fla. We sent a handful of questions to several SCOPE speakers to get a taste of what’s on the agenda. Eric Peacock of myHealthTeams and Taya Skubiak of Bristol-Myers Squibb talk patient enrollment and engagement. 

Dec 10, 2014, 00:00 by Michael Croft

MUNICH, GERMANY - Dec 10, 2014 - Definiens, the global leader in Tissue Phenomics® for oncology diagnostics, today announced the newest version of its leading image analysis software for quantitative digital pathology, Tissue Studio 4

Dec 10, 2014, 00:00 by Michael Croft

NEW YORK, NY - Dec 10, 2014 - Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced the availability of its enriched solution for risk-based monitoring (RBM) of clinical trial sites

Dec 8, 2014, 00:00 by Michael Croft

Businessweek | Merck & Co. agreed to buy Cubist Pharmaceuticals for $8.4 billion in cash to add products to help fight the growing threat of drug-resistant bacteria.

Dec 5, 2014, 08:55 by Michael Croft

Clinical Informatics News | Contributed Commentary | Clinical trials of medicines for major psychiatric disorders often show startlingly high placebo rates — yet clinical psychiatrists know not to expect significant improvements from care and support alone. Trials must be designed with an awareness of factors that can create false placebo effects.

Dec 4, 2014, 10:00 by Michael Croft

Clinical Informatics News Product Brief | Thomson Reuters and Linguamatics today announced a collaboration combining Thomson Reuters’ Cortellis with Linguamatics I2E text analytics platform. The tool—Cortellis Informatics Clinical Text Analytics for I2E—uses a single user interface to apply Linguamatics’ I2E text mining platform to Cortellis content including clinical trial information, epidemiology data, literature, press releases and conference proceedings.

Dec 3, 2014, 00:00 by Michael Croft

WSJ | To spur further development of neglected tropical diseases, Doctors Without Borders believes Congress should fix the priority review voucher program. Judit Rius, U.S. manager and legal policy adviser, explains the proposals to Pharmalot.

Dec 2, 2014, 12:01 by Michael Croft

Clinical Informatics News | Clinical research associates (CRAs) serve as the primary contact point between sites and sponsors, but should this access and position also lead them to be site recruitment managers?

Dec 2, 2014, 00:00 by Michael Croft

CHAPEL HILL, NC, UNITED STATES - Dec 2, 2014 - WHAT: Rho, a full-service contract research organization (CRO), is showcasing its 30-year history of expertise in providing end-to-end product development services to pharmaceutical, biotech and medical device companies at the 8th Annual Medical Device Clinical Trials Conference, taking place December 8-9 in Chicago, Illinois

Dec 1, 2014, 00:00 by Michael Croft

MobiHealthNews | About 68% of Americans are willing to share health care data with researchers, but that group tends to be wealthy, well-educated, and young. However, this group is also most concerned about data privacy.

Dec 1, 2014, 00:00 by Michael Croft

Computerworld | Kaiser Permanente CMIO John Mattison cautions healthcare organizations to take a hard look at the way they approach data to ensure that health information is an asset, not a liability. He also cites the need for a new role: a health data concierge.

Dec 1, 2014, 00:00 by Michael Croft

WEST BEND, WI - Dec 1, 2014 - Spaulding Clinical Research, LLC ("Spaulding Clinical"), a recognized leader in Clinical Research and Device Manufacturing, announced that it has received CRO Leadership Awards in the following categories: Quality, Innovation, Productivity, and Regulatory

Nov 26, 2014, 11:00 by Michael Croft

Clinical Informatics News | The “drug” half of the Food and Drug Administration has been reexamining its role in a changing industry this year, reevaluating both how it reviews new kinds of biotech diagnostics, and where it fits in a healthcare system that has increasingly probed the limits of FDA oversight. Here are some of the big stories to come out of the FDA this year.

Nov 26, 2014, 09:00 by Michael Croft

Forbes | Are consumers really taking their fitness device data to their doctors? Survey says No.

Nov 24, 2014, 00:00 by Michael Croft

NEW YORK, NY - Nov 24, 2014 - AiCure, an artificial intelligence company providing advanced facial recognition and motion-sensing technology to monitor medication ingestion, has announced the start of a major clinical trial to monitor and intervene with patients receiving medication as maintenance therapy for opioid addiction

Nov 24, 2014, 00:00 by Michael Croft

NEW YORK, NY - Nov 24, 2014 - AiCure, an artificial intelligence company providing advanced facial recognition and motion-sensing technology to monitor medication ingestion, has announced the start of a major clinical trial to monitor and intervene with patients receiving medication as maintenance therapy for opioid addiction

Nov 24, 2014, 00:00 by Michael Croft

Outsourcing-Pharma.com | Last week, the NIH and FDA proposed measures that would require the release of summary results of clinical trials for products that are unapproved or unlicensed. CROs have expressed some concern about the transparency initiatives, but were mostly positive.